Acadian Asset Management
SPRB

Acadian Asset Management’s Spruce Biosciences SPRB Stock Holding History

Acadian Asset Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,944
Closed -$74K – 2052
2025
Q2 		$74K Hold
13,944
– – ﹤0.01% 1445
2025
Q1 		$301K Hold
13,944
– – ﹤0.01% 1179
2024
Q4 		$437K Sell
13,944
-2,845
-17% -$104K ﹤0.01% 1106
2024
Q3 		$597K Sell
16,789
-1,451
-8% -$53.1K ﹤0.01% 1044
2024
Q2 		$707K Buy
18,240
+13,322
+271% +$714K ﹤0.01% 1098
2024
Q1 		$289K Buy
+4,918
New +$1.25M ﹤0.01% 1118
2022
Q1 		– Sell
-957
Closed -$318K – 1842
2021
Q4 		$318K Buy
+957
New +$285K ﹤0.01% 1126

Other funds holding SPRB

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management's SPRB Position: Q3 2025 in Review

Acadian Asset Management sold out of Spruce Biosciences (SPRB) in Q3 2025, closing a stake of 13,944 shares — an estimated $74K sold.

Acadian Asset Management first reported a position in SPRB in Q4 2021 and held it in 7 quarters. The position peaked at $707K in Q2 2024. 9 funds tracked by Wall St. Rank hold SPRB as of Q3 2025.

  • Acadian Asset Management reported no remaining Spruce Biosciences position as of Q3 2025 after selling out during the quarter.
  • Acadian Asset Management sold 13,944 Spruce Biosciences shares in Q3 2025, an estimated $74K.
  • Acadian Asset Management first reported a position in Spruce Biosciences in Q4 2021 and held it in 7 quarters.
  • Acadian Asset Management's Spruce Biosciences position peaked at $707K in Q2 2024.
  • 9 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.